ALA Diagnostics — Pre-seed · €0.375M

ALA Diagnostics' first funding round, of €375,000, subscribed by the founders, the existing shareholders and a group of business angels, to develop the ALA Diagnostics EM Kit blood test for multiple sclerosis. Sources only place the round in 2021 without a month, so the date is given as 2021-01; company filings show capital increases resolved on 8 January 2021, 12 March 2021 and 11 January 2022, and Crunchbase and PitchBook list Keiretsu Forum among the company's investors (ALA Diagnostics presented at a Keiretsu Forum Spain investor forum in February 2020), though no source ties Keiretsu to this specific round.